Dosing the antipsychotic medication olanzapine
Olanzapine is a new antipsychotic agent with serotonin/dopamine antagonism action. Efficacy in treating overall psychopathology in acute schizophrenia as measured by the BPRS0-6 total score was demonstrated at 10 mg/day versus placebo; at doses in a 5-20
Nemeroff, C B
core
Central nervous system symptom burden and clinical implications for antiemetic management with olanzapine in AC chemotherapy. [PDF]
Udagawa R +19 more
europepmc +1 more source
Research trends in olanzapine in treating schizophrenia from 2010 to 2026: A bibliometric analysis based on the Web of Science Core Collection. [PDF]
Shu N +5 more
europepmc +1 more source
Zero Events, Limited Precision, and the Interpretation of Olanzapine Safety in Patients with Diabetes Receiving Cisplatin [Response to Letter]. [PDF]
Hayashi T +4 more
europepmc +1 more source
Cardiomyopathy Following Olanzapine Use in an Octogenarian: A Case Report and Literature Review. [PDF]
Abdelmoneim SS +6 more
europepmc +1 more source
Zero Events, Limited Precision, and the Interpretation of Olanzapine Safety in Patients with Diabetes Receiving Cisplatin [Letter]. [PDF]
Shen S, Wang Z.
europepmc +1 more source
Clozapine-Induced Gastrointestinal Hypoperfusion Leading to Bowel Ischemia and Secondary Atrial Fibrillation: A Case Report. [PDF]
Kumar S, Chatterjee M.
europepmc +1 more source

